BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 26432939)

  • 1. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
    Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
    Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice.
    Wu X; Pang G; Zhang YM; Li G; Xu S; Dong L; Stackman RW; Zhang G
    Neurosci Lett; 2015 Oct; 607():23-28. PubMed ID: 26375926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.
    Zayara AE; McIver G; Valdivia PN; Lominac KD; McCreary AC; Szumlinski KK
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):321-35. PubMed ID: 20814782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of Serotonin 5-HT
    Pang G; Wu X; Tao X; Mao R; Liu X; Zhang YM; Li G; Stackman RW; Dong L; Zhang G
    Front Pharmacol; 2016; 7():514. PubMed ID: 28082900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
    Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
    J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice.
    Mori T; Komiya S; Ohya J; Uzawa N; Sugiyama K; Saitoh Y; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2014 Oct; 740():160-7. PubMed ID: 25034809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
    Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
    J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
    Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
    Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
    Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
    Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
    Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
    J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice.
    Pałucha-Poniewiera A; Novák K; Pilc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1454-7. PubMed ID: 19660510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
    Pedrón VT; Varani AP; Balerio GN
    Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a 5-HT7 receptor agonist and antagonist on morphine withdrawal syndrome in mice.
    Shahidi S; Hashemi-Firouzi N
    Neurosci Lett; 2014 Aug; 578():27-32. PubMed ID: 24954075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
    Sharf R; Sarhan M; Dileone RJ
    Biol Psychiatry; 2008 Aug; 64(3):175-83. PubMed ID: 18423425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.